111 related articles for article (PubMed ID: 11978885)
1. CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
Svensson A; Bäckman U; Jonsson E; Larsson R; Christofferson R
Pediatr Res; 2002 May; 51(5):607-11. PubMed ID: 11978885
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
[TBL] [Abstract][Full Text] [Related]
3. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
[TBL] [Abstract][Full Text] [Related]
4. [Experimental therapy with angiogenesis inhibitor TNP-470 on human ovarian cancer transplanted subcutaniously in nude mice].
Kong H; Jin Z; Yao M
Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):556-8. PubMed ID: 12411020
[TBL] [Abstract][Full Text] [Related]
5. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
Hjarnaa PJ; Jonsson E; Latini S; Dhar S; Larsson R; Bramm E; Skov T; Binderup L
Cancer Res; 1999 Nov; 59(22):5751-7. PubMed ID: 10582695
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
Shusterman S; Grupp SA; Maris JM
Med Pediatr Oncol; 2000 Dec; 35(6):673-6. PubMed ID: 11107144
[TBL] [Abstract][Full Text] [Related]
8. Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice.
Johanson V; Arvidsson Y; Kölby L; Bernhardt P; Swärd C; Nilsson O; Ahlman H
Neuroendocrinology; 2005; 82(3-4):171-6. PubMed ID: 16508338
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis can be reduced without significant reduction of tumor growth.
Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
[TBL] [Abstract][Full Text] [Related]
10. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
Schuuring J; Bussink J; Bernsen HJ; Peeters W; van Der Kogel AJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):529-34. PubMed ID: 15667976
[TBL] [Abstract][Full Text] [Related]
11. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
[TBL] [Abstract][Full Text] [Related]
12. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
15. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
16. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
17. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
Wassberg E; Påhlman S; Westlin JE; Christofferson R
Pediatr Res; 1997 Mar; 41(3):327-33. PubMed ID: 9078530
[TBL] [Abstract][Full Text] [Related]
18. Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation.
Gong H; Pöttgen C; Stüben G; Havers W; Stuschke M; Schweigerer L
Int J Cancer; 2003 Sep; 106(5):723-8. PubMed ID: 12866032
[TBL] [Abstract][Full Text] [Related]
19. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
Bischof M; Abdollahi A; Gong P; Stoffregen C; Lipson KE; Debus JU; Weber KJ; Huber PE
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1220-32. PubMed ID: 15519795
[TBL] [Abstract][Full Text] [Related]
20. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
